Critical Outcome Technologies Inc. Share Price Toronto S.E.
Equities
COT
CA22675B1031
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- CAD | - |
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.2M 135M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.47M -334M | Net income 2019 | -2M -2.73M -167M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 55.68K 3.4M | Net cash position 2019 | 24.64K 33.69K 2.06M | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01/15/01 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12/17/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 01/18/01 | |
John C. Drake
CHM | Chairman | - | 20/07/20 |
Alison D. Silva
PSD | President | 46 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- COTQF Stock
- COT Stock